Welcome to the e-CCO Library Archive!

Filter:
P085

Pregnancy-onset IBD is not associated with adverse maternal or neonatal pregnancy outcomes

Authors:

A. Shitrit*1, E. Goldin2, T. Adar2, B. Koslowsky2, D.M. Livovsky1, 2, S. Granovsky- Grisaru3

1Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel, 2Shaare Zedek Medical Center, Digestive diseases institute, Jerusalem, Israel, 3Shaare Zedek Medical Center, Department of obstetrics and gynecology, division of maternal fetal medicine, Jerusalem, Israel

P086.

Development and validation of ELISA to measure serum anti TNFa levels

Authors:

L. Greathead1, P. Kelleher1, A. Steel2, 1Chelsea and Westminster Hospital, Immunology, London, United Kingdom, 2Chelsea and Westminster Hospital, Gastroenterology, London, United Kingdom

P086. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort
P086. Donor dependent efficacy of human mesenchymal stromal cell treatment in experimental colitis
Authors:

I. Molendijk1, V.L. van Zuijlen2, H.W. Verspaget1, W.E. Fibbe2, H. Roelofs2, D.W. Hommes3, 1Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands, 2Leiden University Medical Center, Immunohematology and Blood Transfusion, Netherlands, 3University of California Los Angeles, Digestive Diseases, Los Angeles, United States

P086. Faecal incontinence in inflammatory bowel disease (IBD) and effect on quality of life
P086

The presence of the Epstein-Barr virus is associated to a higher colectomy requirement in patients with Ulcerative Colitis

Authors:

P. Daffra*1, I. Aldecoa2, I. Ordas3, B. Gonzalez2, E. Ricart3, A. Jauregui Amezaga3, J. De Paula1, A. Martinez2, J. Panés3, M. Cuatrecasas2

1Hospital Italiano de Buenos Aires, Gastroenterology, Buenos AIres, Argentina, 2Hospital Clinic, Patología, Barcelona, Spain, 3Hospital Clinic I Provincial, Department of Inflammatory Disease, Barcelona, Spain

P087.

Dendritic cell subsets in the maintenance of gut health and response to bioactives

Authors:

J. Schulthess1, C. Arancibia1, T. Fenton2, M. Travis2, F. Powrie1, 1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom, 2Collaborative Centre for Inflammation Research, University of Manchester, Manchester, United Kingdom

P087. Comparative study of the Quantum Blue rapid test for point of care quantification of faecal calprotectin with an established ELISA method
P087. Differentially expressed microRNAs regulate expression of genes with clinical interest in inflamed colon of patients with ulcerative colitis
Authors:

J. Van der Goten1, L. Van Lommel2, W. Vanhove1, V. De Preter1, M. Ferrante1, F. Schuit2, P. Rutgeerts1, S. Vermeire1, I. Arijs1, 1KU Leuven, Translational Research in GastroIntestinal Disorders (TARGID), Leuven, Belgium, 2KU Leuven, Gene Expression Unit, Department of Molecular Cell Biology, Leuven, Belgium

P087. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease
P087

The study of the related risk factors of steroid resistance with Ulcerative Colitis in the Chinese Han polulation

Authors:

H. Yang*, J. Qian

Peking Union Medical College Hospital, Department of Gastroenterology, Beijing, China

P088.

Delineating lipopolysaccharide signalling pathway in ulcerative colitis through mucosal gene expression analysis

Authors:

A. Balfe1, G. Lennon1, K. Killick2, C. Spillane3, A. Lavelle1, G. Blackshields4, N. Docherty5, C. Coffey6, K. Sheahan1,7, D. Winter8, R. O'Connell1,8, 1University College Dublin, School of Medicine and Medical Science, Dublin, Ireland, 2University College Dublin, Systems Biology Ireland, Dublin, Ireland, 3Trinity College Dublin, Molecular Pathology Research Group, Department of Pathology, Dublin, Ireland, 4Trinity College Dublin, Department of Histopathology and Morbid Anatomy, Dublin, Ireland, 5University College Dublin, Conway Institute of Biomolecular and Biomedical Sciences, School of Medicine and Medical Science, Dublin, Ireland, 6Graduate Entry Medical School, University Hospital Limerick, University of Limerick Ireland, Limerick, Ireland, 7St. Vincent's University Hospital, Department of Histopathology, Dublin, Ireland, 8St. Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland

P088. Differential expression of prolyl hydroxylases 1 and 3 between IBD and non-IBD patients
Authors:

S. Van Welden1, D. Laukens1, M. De Vos1, P. Hindryckx1, 1Ghent University Hospital, Gastroenterology, Ghent, Belgium

P088. Is patient reported outcome (PRO) affected by different follow-up regimes in inflammatory bowel disease (IBD)? A one year prospective, longitudinal comparison of nurse-led versus conventional follow-up
P088. The comparison of three types of capsule endoscopes by small bowel transit time in patients with Crohn's disease
P088

Serum Matrix Metalloproteinase-3 Concentration Correlates with Clinical and Endoscopic Evidence of Ulcerative Colitis

Authors:

K. Kawashima*1, S. Ishihara1, H. Sonoyama1, Y. Tada1, A. Oka1, R. Kusunoki1, N. Fukuba1, N. Oshima1, I. Moriyama1, T. Yuki2, Y. Kinoshita1

1Shimane University School of Medicine, Internal Medicine II, Izumo, Japan, 2Shimane University Hospital, Gastrointestinal Endoscopy, Izumo, Japan

P089.

Decrease of peripheral leucocytes BIM protein expression in Crohn's disease

Authors:

S. Hakim1, M. Fumery1, A. Galmiche2, C. Guignant3, J. Thomas1, F. Brazier1, J.-P. Lemouel1, H. Thiebault1, A. Wacrenier1, E. Nguyen-Khac1, J.-L. Dupas1, 1CHU de Amiens, Gastroenterologie, Amiens, France, 2CHU Amiens, Biochimie, France, 80, Amiens, France, 3CHU Amiens, Immunologie, France, 80, Amiens, France

P089. Differential effects of sulphasalazine, azathioprine and prednisolone on the NF-kB, heparanase, HSP70 and HPRT gene expression in the TNBS-induced intestinal inflammation
Authors:

A. Quaglio1, A. Castilho1, L. Di Stasi1, 1Universidade Estadual Paulista (UNESP), Pharmacology, Botucatu, Brazil

P089. Large burden of disease in early CD-patients in the Biocrohn Registry in Germany
P089. Patients' knowledge of pregnancy-related issues in women with inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’)